National advisory groups and their role in immunization policy-making processes in european countries

Clinical Microbiology and Infection

Volumn 19, Issue 12, 2013, Pages 1096-1105

  Nohynek, H ^a   Wichmann, O ^b   Dancona, F ^c  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b ROBERT KOCH INSTITUTE   (Germany)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Decision making; Europe; Evidence; Immunization programme; Recommendations; Vaccination

Indexed keywords

DIPHTHERIA VACCINE; HAEMOPHILUS INFLUENZAE VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; MEASLES VACCINE; MUMPS VACCINE; PERTUSSIS VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; RUBELLA VACCINE; TETANUS TOXOID; WART VIRUS VACCINE;

DIPHTHERIA; DRUG EFFICACY; DRUG SAFETY; EUROPEAN UNION; HAEMOPHILUS INFECTION; HEALTH CARE POLICY; HEALTH PROGRAM; HEPATITIS B; HUMAN; IMMUNIZATION; MEASLES; MUMPS; PAPILLOMAVIRUS INFECTION; PERTUSSIS; POLIOMYELITIS; PRIORITY JOURNAL; REVIEW; ROTAVIRUS INFECTION; RUBELLA; SEASONAL INFLUENZA; TETANUS; VACCINATION;

DECISION-MAKING; EUROPE; EVIDENCE; IMMUNIZATION PROGRAMME; RECOMMENDATIONS; VACCINATION;

ADVISORY COMMITTEES; DECISION MAKING; EUROPE; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNIZATION PROGRAMS; POLICY MAKING; VACCINES;

EID: 84888032944     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12315     Document Type: Review

References (37)

1. Duclos P. National Immunization Technical Advisory Groups (NITAGs): guidance for their establishment and strengthening. Vaccine 2010; 28 (suppl 1): A18-A25.
2. World Health Organization. Global Vaccine Action Plan 2011-2020. Geneva: WHO Press, 2013.
3. Cuello García CA, Pacheco Alvarado KP, Pérez Gaxiola G. Grading recommendations in clinical practice guidelines: randomised experimental evaluation of four different systems. Arch Dis Child 2011; 96: 723-728.
4. Latham J, Murajda L, Forland F, Jansen A. Capacities, practices and perceptions of evidence-based public health in Europe. Euro Surveill 2013; 18: pii = 20421.
5. Duclos P, Durrheim DN, Reingold AL, Bhutta ZA, Vannice K, Rees H. Developing evidence-based immunization recommendations and GRADE. Vaccine 2012; 31: 12-19.
6. Ahmed F, Temte JL, Campos-Outcalt D, Schünemann HJ; ACIP Evidence Based Recommendations Work Group (EBRWG). Methods for developing evidence-based recommendations by the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC). Vaccine 2011; 29: 9171-9176.
7. Andrews J, Guyatt G, Oxman AD et al. GRADE guidelines: 15. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 2013; 66: 726-735.
8. Guyatt GH, Oxman AD, Sultan S et al. GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol 2011; 64: 1311-1316.
9. Bryson M, Duclos P, Jolly A, Cakmak N. A global look at national Immunization Technical Advisory Groups. Vaccine 2010; 28 (suppl 1): A13-A17.
10. Houweling H, Verweij M, Ruitenberg EJ; National Immunisation Programme Review Committee of the Health Council of the Netherlands. Criteria for inclusion of vaccinations in public programmes. Vaccine 2010; 28: 2924-2931.
11. Erickson LJ, De Wals P, Farand L. An analytical framework for immunization programs in Canada. Vaccine 2005; 23: 2470-2476.
12. National Advisory Committee on Immunization (NACI). Evidence-based recommendations for immunization methods of the National Advisory Committee on Immunization. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2009; 35(ACS-1): 1-10.
13. Nohynek H. The Finnish decision-making process to recommend a new vaccine: from vaccine research to vaccination policy. Eur J Publ Health 2008; 16: 275-280.
14. Standing Committee on Vaccination. Standard Operating Procedure (SOP) of the German Standing Committee on Vaccination (STIKO) for the development of vaccination recommendations. Version 1.0. 24 January 2012. Available at: www.stiko.de/en (last accessed 20 May 2013).
15. Blau J, Sadr-Azodi N, Clementz M et al. Indicators to assess National Immunization Technical Advisory Groups. Vaccine 2013; 31: 2653-2657.
16. European Center for Disease Prevention and Control (ECDC). Information on childhood immunisation schedules in EU/EAA countries. Available at: http://ecdc.europa.eu/en/activities/surveillance/euvac/schedules/Pages/schedules.aspx (last accessed 10 March 2013).
17. Schmitt HJ, Booy R, Weil-Olivier C, Van Damme P, Cohen R, Peltola H. Child vaccination policies in Europe: a report from the Summits of Independent European Vaccination Experts. Lancet Infect Dis 2003; 3: 103-108.
18. Van Damme P, Theeten H, Braeckman T et al. Studie van de vaccinatiegraad bij jonge kindereren en adolescenten in Vlaanderen in 2012. Available at: http://www.zorg-en-gezondheid.be/vaccinatiegraad/ (last accessed 20 May 2013).
19. Iturriza-Gómara M, Cunliffe N. Rotavirus vaccine: a welcome addition to the immunisation schedule in the UK. BMJ 2013; 346: f2347.
20. Jit M, Mangen MJ, Melliez H et al. An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe". Vaccine 2010; 28: 7457-7459.
21. Dorleans F, Giambi C, Dematte L et al. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. Euro Surveill 2010; 15.
22. European Centre for Disease Prevention and Control. Guidance for the introduction of HPV vaccines in EU countries. Stockholm, ECDC, January 2008. Available at: http://ecdc.europa.eu/en/healthtopics/human_papillomavirus_infection/Pages/index.aspx
23. Kanitz EE, Wu LA, Giambi C et al. Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage. Vaccine 2012; 30: 5222-5228.
24. Libster R, Edwards KM. Re-emergence of pertussis: what are the solutions? Expert Rev Vaccines 2012; 11: 1331-1346.
25. Lindsey B, Kampmann B, Jones C. Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants. Curr Opin Infect Dis 2013; 26: 248-253.
26. Wiese-Posselt M, Hellenbrand W. Changes to the varicella and pertussis immunisation schedule in Germany 2009: background, rationale and implementation. Euro Surveill 2010; 15.
27. Mereckiene J, Cotter S, D'Ancona F et al. Differences in national influenza vaccination policies across the European Union, Norway and Iceland 2008-2009. Euro Surveill 2010; 15.
28. Ortiz JR, Englund JA, Neuzil DM. Influenza vaccine for pregnant women in resource-constrained countries: a review of the evidence to inform policy decisions. Vaccine 2011; 29: 4439.
29. Håberg SE, Trogstad L, Gunnes N et al. Risk of fetal death after pandemic influenza virus infection or vaccination. N Engl J Med 2013; 368: 333-340.
30. Final report on Seasonal Influenza Vaccination survey in EU/EEA countries, Season 2010-2011. http://venice.cineca.org/Final_Seasonal_Influenza_2010–11.pdf
31. World Health Organization. Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec 2012; 87: 461-476.
32. Musher DM. Editorial commentary: should 13-valent protein-conjugate pneumococcal vaccine be used routinely in adults? Clin Infect Dis 2012; 55: 265-267.
33. Trück J, Lazarus R, Jonsdottir I, Klugman KP, Pollard AJ. Pneumococcal polysaccharide vaccine efficacy and routine use of conjugate vaccines in infants: there is no need for a vaccine program in older adults at present. Clin Infect Dis 2012; 55: 1577-1579.
34. O'Brien KL, Hochman M, Goldblatt D. Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue? Lancet Infect Dis 2007; 7: 597-606.
35. van Assen S, Agmon-Levin N, Elkayam O et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheumatic Dis 2011; 70: 414-422.
36. Matysiak-Klose D, Ahmed F, Duclos P et al. Report on the 1st international workshop on procedures for the development of evidence-based vaccination recommendations, Berlin, Germany, 22-23 November 2010. Vaccine 2012; 30: 2399-2404.
37. Wiese-Posselt M, Reiter S, Gilsdorf A, Krause G. Needs and obstacles of uniform immunisation schedules in the European Union. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2009; 52: 1099-1104.